STEPHANIE COLEMAN: Open Payments
NPI 1073025623 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 21 payments from 5 companies in 2025. Trend: 2023 $424 · 2024 $904 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $139 |
| Novartis Pharmaceuticals Corporation | 10 | $135 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: JARDIANCE, LEQVIO, FARXIGA, CAMZYOS, WAINUA, AMVUTTRA.
Industry payments across AR — which companies pay providers there.
